These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11324433)

  • 1. Potential mechanisms for cardiovascular protective effect of ethanol.
    Redmond EM; Sitzmann JV; Cahill PA
    Acta Pharmacol Sin; 2000 May; 21(5):385-90. PubMed ID: 11324433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A central role of eNOS in the protective effect of wine against metabolic syndrome.
    Leighton F; Miranda-Rottmann S; Urquiaga I
    Cell Biochem Funct; 2006; 24(4):291-8. PubMed ID: 16170835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of ventricular nitric oxide generating system in chronic alcohol-treated hypertensive rats.
    Husain K; Vazquez-Ortiz M; Lalla J
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):32-7. PubMed ID: 17531158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drink to prevent: review on the cardioprotective mechanisms of alcohol and red wine polyphenols.
    de Lange DW; van de Wiel A
    Semin Vasc Med; 2004 May; 4(2):173-86. PubMed ID: 15478039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol consumption, cardiovascular health, and endothelial function markers.
    Bau PF; Bau CH; Rosito GA; Manfroi WC; Fuchs FD
    Alcohol; 2007 Nov; 41(7):479-88. PubMed ID: 17980786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of inducible nitric oxide synthase in the vascular smooth muscle cells cycle arrest induced by 17 beta-estradiol].
    Yang D; Fu XD; Li YY; Tan Z; Wang TH; Pan JY
    Sheng Li Xue Bao; 2003 Dec; 55(6):684-91. PubMed ID: 14695486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase.
    Yuhanna IS; Zhu Y; Cox BE; Hahner LD; Osborne-Lawrence S; Lu P; Marcel YL; Anderson RG; Mendelsohn ME; Hobbs HH; Shaul PW
    Nat Med; 2001 Jul; 7(7):853-7. PubMed ID: 11433352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol and high-density lipoproteins.
    Devenyi P; Robinson GM; Roncari DA
    Can Med Assoc J; 1980 Nov; 123(10):981-4. PubMed ID: 7004614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholate is required for antiatherogenic effects of ethanol in mouse models.
    Deeg MA
    Alcohol Clin Exp Res; 2003 Sep; 27(9):1499-506. PubMed ID: 14506412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal vascular function despite low levels of high-density lipoprotein cholesterol in carriers of the apolipoprotein A-I(Milano) mutant.
    Gomaraschi M; Baldassarre D; Amato M; Eligini S; Conca P; Sirtori CR; Franceschini G; Calabresi L
    Circulation; 2007 Nov; 116(19):2165-72. PubMed ID: 17967773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
    Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 as a vascular protective factor.
    Conti E; Carrozza C; Capoluongo E; Volpe M; Crea F; Zuppi C; Andreotti F
    Circulation; 2004 Oct; 110(15):2260-5. PubMed ID: 15477425
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of ethanol on circulatory system].
    Jelski W; Alizade Sani T; Szmitkowski M
    Pol Merkur Lekarski; 2006 Sep; 21(123):299-302. PubMed ID: 17163195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation.
    Pandolfi A; Grilli A; Cilli C; Patruno A; Giaccari A; Di Silvestre S; De Lutiis MA; Pellegrini G; Capani F; Consoli A; Felaco M
    J Cell Physiol; 2003 Aug; 196(2):378-85. PubMed ID: 12811832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
    Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoproteins, inflammation and oxidative stress.
    Tabet F; Rye KA
    Clin Sci (Lond); 2009 Jan; 116(2):87-98. PubMed ID: 19076062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-density lipoproteins: the "new" target of cardiovascular medicine].
    Sampietro T; Bigazzi F; Dal Pino B; Puntoni M; Bionda A
    Ital Heart J Suppl; 2005 Jun; 6(6):341-53. PubMed ID: 16013425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol use, vascular disease, and lipid-lowering drugs.
    Kolovou GD; Salpea KD; Anagnostopoulou KK; Mikhailidis DP
    J Pharmacol Exp Ther; 2006 Jul; 318(1):1-7. PubMed ID: 16627749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases.
    Belleville J
    Nutrition; 2002 Feb; 18(2):173-7. PubMed ID: 11844649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-density lipoprotein cholesterol and coronary heart disease.
    Young CE; Karas RH; Kuvin JT
    Cardiol Rev; 2004; 12(2):107-19. PubMed ID: 14766026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.